Biotalk

Latest Episodes
Episode 26: Asia’s 2025 Q1 Report: Global Trends in Biopharma Transactions
During the Asia-focused Episode 26 of Biotalk, Geoff Meyerson, CEO ofLocust Walk, shares fresh insights from Japan, China, and Korea, as featured in our2025 Q1 Report: Global Trends in Biopharma Tra
Biotalk Episode 25: 2025 Q1 Report: Global Trends in Biopharma Transactions
During Episode 25 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Q1 Report: Global Trends in Biopharma Transactions Report, covering capital markets, strategic deals, and regional tr
Biotalk Episode 19: 2024 Q3 Report: Global Trends in Biopharma Transactions
During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2024 Q3 Report: Global Trends in Biopharma Transactions Report.Each quarter, Locust Walks deal team compiles key stati
Biotalk Episode 18: A Conversation with Lindsay Rosenwald of Fortress Biotech
On this episode of Biotalk, Locust WalksAndy MeyersonwelcomesDr. Lindsay Rosenwald, Chairman, President and Chief Executive Officer ofFortress Biotech, a company focused on licensing and developi
Biotalk Episode 16: A Conversation with Stephen Sands of Lazard
On this episode of Biotalk, Locust WalksGeoff MeyersonwelcomesStephen Sands, former Vice Chairman of Investment Banking and Chairman of the Global Healthcare Group, and currently Senior Advisor at